Tue, Apr 29, 10:06 AM (24 days ago)
**Clarivate PLC (CLVT) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $593.7 million, down 4% YoY due to divestitures and product group wind-downs. - **Profit Margins:** Operating loss of $20.8 million, compared to a profit of $5.0 million in Q1 2024. - **Cash Flow:** Operating cash flow of $171.2 million, down 3% YoY. - **Earnings:** Net loss of $103.9 million, compared to a loss of $75.0 million in Q1 2024. - **Debt:** $4,521.1 million in long-term debt, with $354.0 million in cash and cash equivalents. **Key Metrics & Trends:** - **Organic Revenue Growth:** Decreased by 1.0% YoY, impacted by divestitures and wind-downs. - **Annualized Contract Value (ACV):** Decreased by 3.6% YoY due to divestitures. - **Annual Renewal Rate:** 94% for Q1 2025, up from 93% in Q1 2024. - **Adjusted EBITDA:** $233.2 million, down from $236.3 million in Q1 2024. - **Free Cash Flow:** $110.3 million, down 1% YoY. **Segment Performance:** - **Academia & Government (A&G):** Revenue down 4.7% YoY due to divestitures and wind-downs. - **Intellectual Property (IP):** Revenue down 4.1% YoY due to divestitures. - **Life Sciences & Healthcare (LS&H):** Revenue down 4.2% YoY due to wind-downs. **Uncertainties & Future Operations:** - **Value Creation Plan:** Ongoing restructuring expected to complete by end of 2025. - **Legal Proceedings:** Ongoing litigation, but no material impact expected. - **Share Repurchase Program:** $450.0 million remaining under the program. - **Debt Repayments:** Scheduled debt repayments and commitments to be met. **Impact on Future Operations:** - **Cost Savings:** Expected from ongoing restructuring and cost management initiatives. - **Investments:** Continued investment in AI and other technologies to drive growth. - **Market Conditions:** Potential impacts from macroeconomic conditions and regulatory changes.